- Home
- GERN vs WDI Comparison
GERN vs WDI Comparison
Compare GERN & WDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- WDI
- Stock Information
- Founded
- GERN 1990
- WDI 2021
- Country
- GERN United States
- WDI United States
- Employees
- GERN N/A
- WDI N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- WDI Trusts Except Educational Religious and Charitable
- Sector
- GERN Health Care
- WDI Finance
- Exchange
- GERN Nasdaq
- WDI Nasdaq
- Market Cap
- GERN 823.0M
- WDI 775.8M
- IPO Year
- GERN 1996
- WDI N/A
- Fundamental
- Price
- GERN $1.27
- WDI $15.14
- Analyst Decision
- GERN Buy
- WDI
- Analyst Count
- GERN 8
- WDI 0
- Target Price
- GERN $3.71
- WDI N/A
- AVG Volume (30 Days)
- GERN 5.5M
- WDI 192.6K
- Earning Date
- GERN 11-06-2025
- WDI 01-01-0001
- Dividend Yield
- GERN N/A
- WDI 11.80%
- EPS Growth
- GERN N/A
- WDI N/A
- EPS
- GERN N/A
- WDI 1.12
- Revenue
- GERN $164,447,000.00
- WDI N/A
- Revenue This Year
- GERN $175.15
- WDI N/A
- Revenue Next Year
- GERN $56.61
- WDI N/A
- P/E Ratio
- GERN N/A
- WDI $12.82
- Revenue Growth
- GERN 11877.20
- WDI N/A
- 52 Week Low
- GERN $1.09
- WDI $12.16
- 52 Week High
- GERN $4.83
- WDI $14.69
- Technical
- Relative Strength Index (RSI)
- GERN 41.64
- WDI 54.99
- Support Level
- GERN $1.23
- WDI $15.10
- Resistance Level
- GERN $1.33
- WDI $15.25
- Average True Range (ATR)
- GERN 0.07
- WDI 0.09
- MACD
- GERN -0.02
- WDI 0.01
- Stochastic Oscillator
- GERN 13.79
- WDI 62.07
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About WDI Western Asset Diversified Income Fund of Beneficial Interest
Western Asset Diversified Income Fund is a newly-organized, diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income.